Although lhcgr has been identified as a potential drug target for cancer therapy and methods to apply this have been refined, there have so far been very few studies showing how these anti-cancer drugs affect the expression of lhcgr (Cavalli et al., 2016; Gao et al., 2018). This evidence concerns the gene LHCGR and cancer.